Inhibition of endothelial Cdk5 reduces tumor growth by promoting non-productive angiogenesis

Therapeutic success of VEGF-based anti-angiogenic tumor therapy is limited due to resistance. Thus, new strategies for anti-angiogenic cancer therapy based on novel targets are urgently required. Our previous in vitro work suggested that small molecule Cdk5 inhibitors affect angiogenic processes suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Merk, Henriette, Zhang, Siwei, Lehr, Thorsten, Müller, Christoph, Ulrich, Melanie, Bibb, James A., Adams, Ralf H., Bracher, Franz, Zahler, Stefan, Vollmar, Angelika M., Liebl, Johanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868742/
https://www.ncbi.nlm.nih.gov/pubmed/26755662
http://dx.doi.org/10.18632/oncotarget.6842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868742/
https://www.ncbi.nlm.nih.gov/pubmed/26755662
http://dx.doi.org/10.18632/oncotarget.6842

Ejemplares similares